Systemic effects of inhaled corticosteroids : Current Opinion in Pulmonary Medicine Systemic
effects of inhaled corticosteroids : Current Opinion in Pulmonary Medicine Log in or Register …

BACKGROUND: Inhaled corticosteroids (ICSs) are the most effective therapy for the
management of persistent asthma. The aim of ICS therapy is to achieve a high anti …

Inhaled corticosteroids (ICSs) are used extensively in the treatment of asthma and chronic
obstructive pulmonary disease (COPD) due to their broad antiinflammatory effects. They …

Although twice-daily administration of ICS is often better to optimize asthma parameters, in
many patients, asthma can be sufficiently controlled by a once-daily regimen of most ICS. An …

This narrative review provides evidence-based explanations to some of the common clinical
concerns regarding inhaled corticosteroids. Inhaled corticosteroids are the treatment of …

The National Asthma Education and Prevention Program 1997 guidelines and 2002 update
provide an overview of potential local and systemic side effects associated with inhaled …

Corticosteroids have a significant role in the management of asthma due to their powerful
anti-inflammatory actions. However, when given orally, they cause significant and unwanted …

Inhaled corticosteroids are being given to more patients, at increasing doses and for longer
periods of time. This has led to renewed concern about side-effects, particularly when higher …

Asthma is a chronic inflammatory disease characterized by symptoms of cough, dyspnea,
chest tightness, and wheeze. Inhaled corticosteroids (ICS) have been recommended as …

Inhaled corticosteroids (ICS) are the standard of care in asthma and are widely used in the
treatment of patients with chronic obstructive pulmonary disease. High-dose regimens and …